You nailed it. That’s how I perceived it as well. I though Durrant did a great job speaking as a class act professional. I confident they will get EUA from the manner in which he speaks about them.

I appreciate your post. At times I become very frustrated and fall down the FDA conspiracy rabbit hole. It’s nice to be pulled away from those thoughts and keep an open mind about Lenz EUA.

Good find.

Thanks that’s good information to know.

Honestly I don’t know the answer. However, I have seen several stocks rally this year on laughable news. The market is turning into a speculative circus in my opinion.
Good stocks are hated and garbage stocks a loved. Lol

I have no issue with the article. It’s a fair point to bring up. If shorts want to add, that’s fine. They will get squeezed even worse when HGEN is granted EUA!

Good. Bring on the shorts, the more the better. They are gun powder, for a giant squeeze. When HGEN files for EUA this should massively overshoot to the upside.

I agree with you. Speculation doesn’t matter at this point. The data and potential EUA will have the final say in where this stock ends up. If the data is good, the shorts are gonna get smoked. Way more upside than downside on this IMO.

It is market manipulation. Heavy $7.5 strike Put buyers is trying to force a reverse gamma squeeze. I’m sick of this options manipulated short term gamma trading market.

Despite the short term pain, Lenz will do the all talking when the Phase 3 data is presented.

Old old news, was priced in a long time ago. Company has moved on.

I’m ready to back up the truck at the 200 day MA. Bring it

How is this not over $20? Could easily be over $30 in the next month.

This should be trading at $30. Over $20 easily IMO

10-20B is too much in my opinion for a limited pipeline. Hard to estimate, but perhaps Lenz. could generate a few billion in revenue over time.

GILD should buy out HGEN for $25-$30 a share. That would be one hell of a team. I could it happening.

This stock should trade above $15 easily. $20-$25 fair valuation IMO

$15-$16 coming tomorrow or Wednesday. IMO

Market has fallen asleep on HGEN. Only reason the stock isn’t $20 is lack of mainstream news. If they get EAU, I expect a massive pop.

Wish I had bought more at $9 today. Oh well.

Several of my friends, only have Robinhood. They all were interested in buying in April and May but couldn’t. Now they can get in at a decent share price.

This is going to explode once listed on the NASDAQ. Right now, none of the Robinhood traders can buy on OTC. The second the NASDAQ opens, it will get bid up IMO. Even with the additional share offer, this is easily a 1 Billion dollar market cap stock, which is still $20+ a share.

Tomorrow this pops to $12.5 IMO

Yes, I’ve held this stock for years. Been a long journey.

I could see this up 100% in the next two weeks. IMO

Feeling a big spike into close!

My crystal ball says the bottom is going to be $1.35-$1.40 area. At least that where is see support.

Wouldn’t be surprised to see this trading at $50 in a couple of month on positive clinical data. ($10 pre split)

The reverse split makes the Nasdaq listing much MORE likely. That is the only reason they are doing it.

Will happily buy any dip on this should we test $3. How is this stock not over $5 right now. No jump on news of likely being exclusive partner with GILD. Makes sense lol

This stock is easily worth $4 and will probably go to $8 if the phase III trial is successful. And it shouldn’t need news to get back the where it was. Lenzilumab could be a billion + dollar selling drug. Their market cap is well under 1 billion which is crazy.

Rally back over $4 today. I can feel it!

Just added at $2.49. Thanks to all the idiots selling. ;)

Will be loading up the boat at $2.5 should it fall there. Nothing has changed fundamentally here as I believe in the success of the phase 3 trial. Monoclonal antibodies could be huge. The NIH selecting this trial was a huge vote of confidence IMO. If Mr. Market wants to quote a cheap price today, that fine with me.

This is a $10 stock. NIH trial new gives a huge vote of confident to Lenz. I’m a lot more bullish now at $5 than I was a month ago.

If this goes below $2, I’ll be loading up. Felt like this was somewhat of a pump and dump at the top. But this sell off doesn’t change the positive outlook for Lenz.

Kabooom!

Haha love the optimism.

Imagine the pop on $HGEN if they announced a COVID PR for a cocktail of Lenz and Remdismir. Maybe it pops to $2.50. Maybe I’m dreaming. Go Lenz!

“We are encouraged by our experiences in the compassionate use patients treated with lenzilumab and look forward to working with stakeholders to share these data," said Dr. Cameron Durrant, chief executive officer of Humanigen.

https://www.accesswire.com/588642/First-Patient-Dosed-in-FDA-Approved-Phase-III-Lenzilumab-Study-for-COVID-19